紫元元（08223）今日盘中大涨6.16%，引起投资者关注。这一显著涨幅主要源于公司最新宣布的融资计划。
根据公司公告，紫元元于2025年4月1日与认购人Dansey P2 Limited签订了可换股债券认购协议。公司将发行本金总额为1000万港元的可换股债券，初始换股价为每股1.51港元，较4月1日收盘价1.46港元溢价约3.4%。若可换股债券所附带的换股权获悉数行使，公司将发行最多662.25万股新股份，约占当前已发行股份总数的1.54%。
此次可换股债券发行的所得款项净额约为950万港元。公司计划将这笔资金用于三个主要方面：约47%用于收购及开发医疗设备贸易和消耗品业务的新项目，以支持公司现有业务；约21%用于偿还短期贷款；剩余约32%将作为集团的一般营运资金。这一融资计划显示出公司在扩展业务、优化财务结构方面的积极举措，可能是推动股价上涨的主要原因。投资者似乎对公司的未来发展前景持乐观态度，认为这笔资金将有助于紫元元加强其在医疗器械行业的竞争力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.